Pipeline
Design text placeholder, please provide customer.
Pipeline

Product

Description

Indication

Discovery

Preclinical

IND filing

Phase l clinical trial

  • PBMC-NK

  • Tumor

  • NKR-NK

  • Tumor

  • NKR-NK

  • Tumor

  • NKR-NK+

  • Tumor

  • NKR-NK+

  • Tumor

  • Bi-NKR+

  • Tumor

  • Bi-NKR+

  • Tumor

  • Syn-NK+

  • Tumor

NK-010 - Ongoing investigative clinical trials (4 Phase I trails)
Research Center Indication Number of enrollment Progression
Application submission Ethical Approval Start
First Affiliated Hospital of USTC Advanced solid after multi-line therapy (Safety evaluation) 50
Peking University People's Hospital Elderly recurrence (not post-transplant recurrence) or refractory AML 10
First Affiliated Hospital of USTC Ovarian cancer (ascites) 30
First Affiliated Hospital of USTC Solid tumor and hematologic tumor in children (under 18 years old) 30

© Copyright by CSPC All rights reserved. ICP备字:沪ICP备2022013361号-1